logo

Seagen Inc (SGEN)



Trade SGEN now with
  Date
  Headline
5/23/2022 8:05:09 AM Seagen Announces Positive Topline Results Of Phase 2 Trial Of TUKYSA With Trastuzumab In HER2-Positive MCRC
5/16/2022 6:03:26 AM Seagen Reveals Resignation Of CEO Clay Siegall; Says Roger Dansey To Continue As Interim CEO
5/9/2022 6:03:12 AM Seagen President, CEO And Chairman Clay Siegall Takes Leave Of Absence
4/28/2022 4:20:01 PM Seagen Q1 Loss/share $0.74 Vs. Loss $0.67 Year Ago
4/20/2022 9:03:56 AM Seagen Plans To Build New Facility In Everett, Washington
3/16/2022 6:36:51 AM Seagen And Sanofi Collaborate To Commercialize Multiple Novel Antibody-Drug Conjugates For Up To Three Cancer Targets
2/28/2022 8:08:56 AM Astellas Announces CHMP Confirms Positive Opinion For PADCEV In Locally Advanced Or Metastatic Urothelial Cancer
2/10/2022 5:14:10 PM William Blair Reiterates Seagen Inc (SGEN) At Outperform
2/9/2022 4:08:29 PM Seagen Q4 Loss/share $0.95 Vs. Profit $0.90 Year Ago
2/9/2022 4:07:56 PM Seagen Inc Q4 Earnings Summary